Stryker Corporation

XNYSHealth care

Last traded price · USD

$335.01

+7.88%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:29 IST · A quote does not mean the product is available to trade on your account.

Day's open: $327.94
Previous close: $310.55
Volume: 6.5M
Day's high: $342.65
Day's low: $322.00

In brief

Stryker Corporation is a health care company listed on the New York Stock Exchange, valued at about $128.50B.
Its shares closed at $339.65 on 4 Nov 2026, down 6.3% over the past year.
From India you can buy SYK in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Stryker Corporation (SYK) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole SYK share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade SYK options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Rose 9.4% on 4 Nov 2026
The 4 Nov 2026 gain of 9.4% was 6.6× its average daily move of 1.4% over the past year, and its largest one-day gain since 1 Feb 2023.
Daily closes, split-adjusted · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $339.65 was 16.3% above its 50-day average ($292.09) and 5.1% above its 200-day average ($323.17). It has closed above the 200-day for 1 session, since 4 Nov 2026. The 50-day average crossed below the 200-day on 15 Oct 2025, 265 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Behind SPY and its sector fund XLV over 1 year
1 month: +22.1% (SPY −1.6%, XLV +13.5%). 3 months: +0.8% (SPY −0.4%, XLV +15.5%). 1 year: −6.3% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: SYK, SPY and XLV · as of 4 Nov 2026
Volume 2.4× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 6.5M shares was 2.4× the average of the 30 sessions before it (2.7M), as the price rose 9.4%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
RSI(14) at 70.3, 70 or above
The 14-session relative strength index closed at 70.3 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+22.1%

6 months+16.2%

1 year−6.3%

5 years+25.8%

Newswire

About

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.

Website

Notable moves

November 4, 2026
+9.37%
September 8, 2026
−8.81%
February 1, 2023
+9.91%

Stryker Corporation

XNYSHealth care

Last traded price · USD

$335.01

+7.88%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:29 IST · A quote does not mean the product is available to trade on your account.

Day's open: $327.94
Previous close: $310.55
Volume: 6.5M
Day's high: $342.65
Day's low: $322.00

In brief

Stryker Corporation is a health care company listed on the New York Stock Exchange, valued at about $128.50B.
Its shares closed at $339.65 on 4 Nov 2026, down 6.3% over the past year.
From India you can buy SYK in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Stryker Corporation (SYK) shares from India?

Do I need the price of a whole SYK share to invest?

How much can I invest in US stocks in a year?

Can I trade SYK options or futures?

Insights

Quotes run fifteen minutes behind.

Rose 9.4% on 4 Nov 2026
The 4 Nov 2026 gain of 9.4% was 6.6× its average daily move of 1.4% over the past year, and its largest one-day gain since 1 Feb 2023.
Daily closes, split-adjusted · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $339.65 was 16.3% above its 50-day average ($292.09) and 5.1% above its 200-day average ($323.17). It has closed above the 200-day for 1 session, since 4 Nov 2026. The 50-day average crossed below the 200-day on 15 Oct 2025, 265 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Behind SPY and its sector fund XLV over 1 year
1 month: +22.1% (SPY −1.6%, XLV +13.5%). 3 months: +0.8% (SPY −0.4%, XLV +15.5%). 1 year: −6.3% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: SYK, SPY and XLV · as of 4 Nov 2026
Volume 2.4× its 30-session average on 4 Nov 2026
4 Nov 2026 volume of 6.5M shares was 2.4× the average of the 30 sessions before it (2.7M), as the price rose 9.4%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
RSI(14) at 70.3, 70 or above
The 14-session relative strength index closed at 70.3 on 4 Nov 2026, its 1st session at 70 or above. By convention a reading of 70 or above is called overbought and 30 or below oversold.
Daily closes, split-adjusted; Wilder's 14-session RSI · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+22.1%

6 months+16.2%

1 year−6.3%

5 years+25.8%

Newswire

About

Website

Notable moves

November 4, 2026
+9.37%
September 8, 2026
−8.81%
February 1, 2023
+9.91%

Stryker Corporation

Stryker Corporation in brief

Rose 9.4% on 4 Nov 2026

Above its 50- and 200-day averages

Behind SPY and its sector fund XLV over 1 year

Volume 2.4× its 30-session average on 4 Nov 2026

RSI(14) at 70.3, 70 or above

Stryker Corporation

Stryker Corporation in brief

Rose 9.4% on 4 Nov 2026

Above its 50- and 200-day averages

Behind SPY and its sector fund XLV over 1 year

Volume 2.4× its 30-session average on 4 Nov 2026

RSI(14) at 70.3, 70 or above